Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration.
about
Active metabolites as antidepressant drugs: the role of norquetiapine in the mechanism of action of quetiapine in the treatment of mood disordersMagnetic resonance spectroscopy in anxiety disorders.Modern chromatographic and electrophoretic measurements of antidepressants and their metabolites in biofluids.MR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases.AGN-2979, an inhibitor of tryptophan hydroxylase activation, does not affect serotonin synthesis in Flinders Sensitive Line rats, a rat model of depression, but produces a significant effect in Flinders Resistant Line rats.The use of toxicokinetics for the safety assessment of drugs acting in the brain.Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function.Drug metabolism: from experiments to regulatory aspects.Inhibition of the Serotonin Transporter Is Altered by Metabolites of Selective Serotonin and Norepinephrine Reuptake Inhibitors and Represents a Caution to Acute or Chronic Treatment Paradigms.Effects of fluoxetine on the reproductive axis of female goldfish (Carassius auratus).Quantitation of dexfenfluramine/d-norfenfluramine concentration in primate brain using 19F NMR spectroscopy.Effects of diverse psychopharmacological substances on the activity of brain prolyl oligopeptidase.
P2860
Q21129108-43B71687-CB49-46A4-BAE1-E2904ACF411DQ31054356-803003B6-9C57-4EFB-80A6-9EFE7A3F25BAQ33759563-AE07EBAD-4175-46BD-853C-EE2C971C0BDBQ36598509-4BA74E7A-C675-48EC-8ABC-586B0DC44D7EQ37423443-27CF6E18-EABE-4192-BC96-ECE4721D70A6Q40945435-7161557E-68E4-47EF-AD2D-D73A44E37BE0Q40971013-F0B63E43-C7BA-4084-A05A-52F25A247F80Q41570003-CB64294F-2E4B-44D9-8E7C-D7CD2D3513ACQ42256088-16A11B09-4075-409E-A14A-E82D9377F578Q46395105-A326E57F-3210-43F2-9430-CAFC3F49565AQ48560352-1A799029-D74A-4FAB-8899-3BD28F349D13Q51038136-C7749C03-4EE9-4E8D-B1BD-DEF8EC18F496
P2860
Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Accumulation of fluoxetine and ...... ng therapeutic administration.
@en
Accumulation of fluoxetine and ...... ng therapeutic administration.
@nl
type
label
Accumulation of fluoxetine and ...... ng therapeutic administration.
@en
Accumulation of fluoxetine and ...... ng therapeutic administration.
@nl
prefLabel
Accumulation of fluoxetine and ...... ng therapeutic administration.
@en
Accumulation of fluoxetine and ...... ng therapeutic administration.
@nl
P2093
P356
P1476
Accumulation of fluoxetine and ...... ng therapeutic administration.
@en
P2093
A R Guimaraes
J D Pearlman
J F Rosenbaum
P F Renshaw
P R Puopolo
R G Gonzalez
P304
P356
10.1176/AJP.149.11.1592
P407
P577
1992-11-01T00:00:00Z